Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eye (Lond) ; 18(9): 893-9, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15002024

RESUMO

AIMS: To compare the diurnal intraocular pressure (IOP) efficacy and safety of timolol vs latanoprost in subjects with exfoliation glaucoma (XFG). METHODS: A 3-month prospective, single-masked, active-controlled, parallel comparison performed in six centres in Greece that randomized subjects in a 1 : 1 ratio to either latanoprost in the evening (2000 hours) and placebo in the morning (0800 hours), or timolol twice daily (0800 and 2000 hours). RESULTS: In all, 103 subjects completed the study. After 3 months of chronic dosing, the latanoprost group exhibited a trend to a greater diurnal IOP reduction from an untreated baseline (24.9+/-3.2-17.4+/-2.9) compared with timolol (24.7+/-2.8-18.3+/-1.9 mmHg) (P=0.07). Latanoprost showed a significantly greater IOP reduction at 0800 hours (-8.5 vs -6.0 mm Hg for timolol, P<0.0001) whereas no difference was observed between the two medications at 1000, 1400, and 2000 hours after a Bonferroni Correction. In addition, latanoprost demonstrated a narrower range of diurnal IOP (2.4) than timolol (3.2 mmHg)(P=0.0017). Safety was similar between groups, except there was more conjunctival hyperaemia with latanoprost (n=8) than timolol (n=1)(P=0.01). CONCLUSIONS: This study suggests that latanoprost provides a statistically lower 08:00-hour IOP and better range of IOP than timolol in the treatment of XFG glaucoma.


Assuntos
Anti-Hipertensivos/uso terapêutico , Síndrome de Exfoliação/tratamento farmacológico , Glaucoma de Ângulo Aberto/tratamento farmacológico , Prostaglandinas F Sintéticas/uso terapêutico , Timolol/uso terapêutico , Adulto , Idoso , Anti-Hipertensivos/efeitos adversos , Ritmo Circadiano/efeitos dos fármacos , Síndrome de Exfoliação/fisiopatologia , Feminino , Glaucoma de Ângulo Aberto/fisiopatologia , Humanos , Pressão Intraocular/efeitos dos fármacos , Latanoprosta , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Prostaglandinas F Sintéticas/efeitos adversos , Método Simples-Cego , Timolol/efeitos adversos
2.
Acta Ophthalmol Scand ; 77(4): 467-70, 1999 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-10463425

RESUMO

PURPOSE: To provide evidence for the hypothesis that dynamic iridolenticular contact predisposes to the development of glaucoma in exfoliation syndrome (XFS). METHODS: We present four patients with bilateral XFS and unilateral exfoliation glaucoma (XFG) whose normotensive eyes had suffered traumatic loss of dynamic iridolenticular contact. RESULTS: All 4 patients had bilateral XFS and developed XFG only in the untraumatized eyes. One patient had loss of iridolenticular contact in the traumatized eye, two had a nonreactive pupil, and one had had intracapsular cataract extraction at age 28. CONCLUSIONS: Loss of dynamic iridolenticular contact may help to protect against development of glaucoma in eyes with XFS.


Assuntos
Síndrome de Exfoliação/complicações , Glaucoma de Ângulo Aberto/prevenção & controle , Doenças da Íris/etiologia , Doenças do Cristalino/etiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Síndrome de Exfoliação/patologia , Ferimentos Oculares Penetrantes/cirurgia , Seguimentos , Glaucoma de Ângulo Aberto/etiologia , Humanos , Doenças da Íris/patologia , Doenças do Cristalino/patologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Aderências Teciduais/etiologia , Malha Trabecular/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...